Detalhe da pesquisa
1.
Immune Checkpoint Inhibitor Is Associated with Improved Survival in Advanced Non-small Cell Lung Cancer Occurring in Patients with Autoimmune Disease.
Biol Pharm Bull
; 47(2): 454-461, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38382998